In normal and cancer cells, AA scarcity is sensed by the Eukaryotic Translation Initiation Factor 2 Alpha Kinase 4 (eIF2AK4 also known as GCN2), which phosphorylates eukaryotic translation initiation factor 2A (eIF2α), to switch Cap-dependent/Cap-independent translation, promoting the expression of AA biosynthetic enzymes and transporters as an adaptive response5,52. Here, EIF2A is linked to cancer.